ACE and chronic kidney disease: These treatment patterns are in line with the recommendations of the KDIGO 2024 guidelines for CKD [8] and KDIGO 2021 guidelines for the management of blood pressure in CKD [20] that indicate the use of ACE inhibitors or angiotensin II receptor blockers as a first-line therapy for blood pressure control when albuminuria is present.